Brief: Scandinavian Real Heart To Present New Data From Two Preclinical Studies
05/09/2024 14:33
Sept 5 (Reuters) - Scandinavian Real Heart AB
HEART.ST :
* WILL PRESENT NEW DATA FROM TWO SUCCESSFUL PRECLINICAL
STUDIES
EVALUATING THE TREATMENT SAFETY OF ITS TOTAL ARTIFICIAL HEART
* RESULTS FROM FIRST STUDY SHOW THAT REALHEART® TAH
PRESERVES VON
WILLEBRAND FACTOR (VWF)
* VWF IS A PROTEIN THAT IS ESSENTIAL FOR BLOOD CLOTTING AND
PREVENTION OF INTERNAL BLEEDING
Source text for Eikon: ID:nMFNb6bR4f
Further company coverage: HEART.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))